1.Compilation Instructions for Expert Consensus on Clinical Application of Dieda Huoxue Capsules
Yuhang MENG ; Jinghua GAO ; Minshan FENG ; Quan JI ; Jin JIN ; Ting CHENG ; Yongyao LI ; Yuanyuan LI ; Xin CUI ; Yanming XIE
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(20):177-183
The Compilation Instructions for Expert Consensus on Clinical Application of Dieda Huoxue capsules systematically expound the development methods and evidence-based basis of this consensus. In view of the weak clinical application evidence and ambiguous indications of Dieda Huoxue capsules, the Institute of Basic Research in Clinical Medicine of the China Academy of Chinese Medical Sciences and Wangjing Hospital took the lead and collaborated with 33 experts from 28 medical institutions nationwide. They strictly followed the World Health Organization (WHO) guideline-making norms and the Grading of Recommendations Assessment, Development and Evaluations (GRADE) evidence-grading system and completed the compilation through multidisciplinary cooperation. The workflow included constructing clinical questions (19 items were screened by the nominal group technique), retrieving evidence (from Chinese and English databases and grey literature), assessing safety (integrating drug monitoring data and clinical investigations), and forming recommendations and consensus suggestions (3 recommendations were reached via the GRADE grid method, and 16 consensus suggestions were reached by the majority vote rule). The results indicate that the consensus clearly states that this medicine (Dieda Huoxue capsules) is applicable to conditions like traumatic injury, blood stasis-induced pain, and sudden lumbar sprains. The recommended dose is 6 capsules each time, twice a day. Combining oral administration with external application can enhance the efficacy, and elderly patients should take the medicine at intervals. Safety monitoring suggests that it should be used with caution in people with a bleeding tendency and those with an allergic constitution. The compilation process involved three rounds of reviews by internal and external experts. Literature analysis, the Delphi method, and clinical applicability tests were employed to ensure methodological rigor. The compilation instructions comprehensively present key aspects such as project approval and registration, conflict-of-interest statements, and evidence evaluation through 12 appendices, providing methodological support for the clinical translation of the consensus. In the future, it will be continuously improved through a dynamic revision mechanism.
2.Randomized controlled study of olanzapine oral soluble film versus intramuscular haloperidol against agitated behaviour in male inpatients with schizophrenia
Longlong SUN ; Yanhai WU ; Yexin LI ; Chenchen TAN ; Shu CUI ; Jinghua ZHAO
Sichuan Mental Health 2024;37(5):409-413
Background Agitated behaviour in male patients with schizophrenia can lead to serious consequences for the individual and the society.Non-invasive drug delivery may help to rapidly control agitation and improve the overall patient satisfaction,but there are limited studies on the efficacy of olanzapine oral soluble film for the treatment of agitated behaviour in patients with schizophrenia.Objective To compare the efficacy and safety profile of olanzapine oral soluble film versus intramuscular haloperidol against agitated behaviour in male patients with schizophrenia,so as to provide a reference for the treatment of agitated behaviour.Methods From May 2022 to July 2023,a consecutive sample of schizophrenic patients(n=44)with agitated behaviour who met the Diagnostic and Statistical Manual of Mental Disorders,fifth edition(DSM-5)were recruited in the male psychiatric closed ward of the Third People's Hospital of Fuyang.Patients were assigned into two groups using the random number table method,each with 22 cases.Study group was treated with olanzapine oral soluble film 10 mg/d,while control group was given intramuscular haloperidol 8 mg/d.The severity of agitated behaviour was determined using Positive and Negative Syndrome Scale-Excited Component(PANSS-EC)and Agitation Calmness Evaluation Scale(ACES)at the baseline and after 6 h of drug administration.The treatment response rate was calculated based on the reduction of PANSS-EC score,and the drug side effects were assessed using Rating Scale for Extrapyramidal Side Effects(RSESE)and Barnes Akathisia Rating Scale(BARS)after 6 h of drug administration.Results After 6 h of drug administration,no statistical difference was reported in PANSS-EC score and ACES score between two groups(F=0.039,0.082,P>0.05),and the treatment response rate yielded no statistical difference between two groups(χ2=0.419,P=0.517),while study group reported a lower incidence rate of adverse reactions compared with control group,with statistically significant difference(P=0.031).BARS scores noted no statistical significant difference between two groups(t=0.587,P=0.561),whereas study group scored lower on RSES compared to control group,with a statistical difference(t=-7.367,P<0.01).Conclusion In the treatment of agitation in male patients with schizophrenia,the efficacy of olanzapine oral soluble film is comparable to that of intramuscular haloperidol,while the safety profile of the former is superior to that of the latter.
3.Application of color doppler flow imaging in the diagnosis of ocular toxocariasis in children
Wei CHEN ; Wenli YANG ; Jinghua LIU ; Dongjun LI ; Ziyang WANG ; Qi ZHAO ; Yifeng LI ; Rui CUI ; Lin SHEN ; Qian LIU
Chinese Journal of Ocular Fundus Diseases 2024;40(1):39-43
Objective:To summarize the characteristics of color doppler flow imaging (CDFI) of ocular toxocariasis (OT) in children.Methods:A retrospective clinical study. From July 2014 to June 2020, 61 OT patients with 61 eyes diagnosed through clinical and laboratory testing in the Department of Ophthalmology of Beijing Tongren Hospital of Capital Medical University were included in the study. There were 45 males with 45 eyes and 16 females with 16 eye (male: female=2.81:1). Age were (6.93±2.50) years. The right eye and left eye were 29 and 32 eyes, respectively. Both eyes of the patient underwent two-dimensional ultrasound and CDFI examination. Two dimensional ultrasound was used to estimate the axial length (AL) of the affected eyes and healthy eyes on the opposite side. Among them, 52 cases were measured for AL using optical biometry and/or A-mode ultrasound. Vitreoretinal surgery was performed within one week after ultrasound examination. Two-dimensional ultrasound was used to observe the morphology of vitreous opacity, its connection to the eyeball wall, and whether posterior vitreous detachment and retinal detachment have occurred. CDFI examination was used to observe the presence of blood flow signals on the pathological membrane. The detection rates of different forms of vitreous opacity and traction retinal detachment were calculated. The location of proliferative lesions in the eye was analyzed. Paired t-test was performed to compare the AL of the affected eye and the healthy eye on the opposite side. Perform Kappa consistency test on the location of proliferative lesions was used during CDFI examination and vitreoretinal surgery. Results:All affected eyes have varying degrees of vitreous opacity. Among them, 23 eyes (37.7%, 23/61) showed typical "Christmas tree" like turbidity; 27 eyes (44.3%, 27/61) had clustered and striped echoes; 9 eyes (14.8%, 9/61) had weak punctate and strip echoes. Two eyes (3.3%, 2/61) showed a large amount of dense punctate and strip-shaped echoes. There were 50 eyes (82.0%, 50/61) with traction retinal detachment, of which 46 eyes (92.0%, 46/50) had visible blood flow signals on the detached retina, and the remaining 4 eyes (8.0%, 4/50) had no blood flow signals. During CDFI and surgery, there were 5 (8.2%, 5/61) and 4 (6.6%, 4/61) eyes with visible proliferative lesions in the periphery, respectively; 18 (29.5%, 18/61) and 14 (23.0%, 14/61) eyes were distributed in the posterior pole, respectively; there were 38 (62.3%, 38/61) and 43 (70.5%, 43/61) eyes with both peripheral and posterior polar regions, respectively. The consistency between CDFI and surgery in detecting the location of proliferative lesions was good ( κ=0.832, 95% confidence interval 0.691-0.973, P<0.001). The two-dimensional ultrasound measurement results showed that the AL of the affected eye was shorter than that of the contralateral healthy eye in 46 cases (75.4%, 46/61). Among the 52 patients who underwent AL biometry, the AL of the affected eye was shorter than that of the contralateral healthy eye by (0.63±0.68) mm, and the difference was statistically significant ( t=-6.738, P<0.05). Conclusions:CDFI can clearly display various intraocular lesions (vitreous opacity and traction retinal detachment) and eyeball sizes in children with OT. Vitreous opacity is often manifested as "Christmas tree" like, clustered, strip-shaped.
4.Clinical Comprehensive Evaluation of Jintiange Capsules in Treatment of Osteoporosis
Xin CUI ; Sheng HAN ; Jinghua GAO ; Zhifei WANG ; Qiang ZHANG ; Xu WEI ; Yanming XIE
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(11):151-159
ObjectiveTo comprehensively evaluate the clinical value of Jintiange Capsules (JCs) in the treatment of osteoporosis (OP) and clarify the intrinsic advantages and clinical treatment characteristics of JCs, providing references for relevant departments of national health and medicine decision-making and the basis and clues for clinical and basic in-depth research. MethodBased on evidence-based medical evidence, this study integrated quantitative and qualitative methods and combined with questionnaires, official website data, human experience, pharmacoeconomic evaluation, and other research methods. From the effectiveness, safety, economy, innovation, suitability, accessibility, and traditional Chinese medicine (TCM) characteristics of the '6+1' dimension, the clinical evidence and value of JCs in the treatment of OP were comprehensively evaluated, forming the 'clinical evidence and value evaluation index'. The comprehensive evaluation of clinical value was based on the multi-criteria decision analysis framework. The expert meeting method was used to empower each dimension and value index. The clinical evidence and value evaluation software of Chinese patent medicine (CSC v2.0) was used to calculate the total value score, and the clinical advantages of JCs were comprehensively evaluated. ResultBased on randomized controlled clinical studies and systematic review, data analysis of spontaneous reporting system (SRS), case reports, non-clinical safety studies, etc., serious adverse drug reactions (ADRs) were reported after the launch of this product monitored by SRS, mainly involving abnormal liver function and adverse reactions of cardiovascular system. Therefore, the safety evidence adequacy of this product should be further improved, and the safety evaluation was Grade B. Meta-analysis showed that JCs were superior to the control group in improving the total clinical effective rate, improving bone mineral density, reducing visual analogue scale (VAS) score, and shortening fracture healing time. Combined with Grading of Recommendations Assessment, Development and Evaluation (GRADE) evidence evaluation, the comprehensive evaluation of effectiveness was Grade A. Pharmacoeconomic evaluation showed that JCs combined with calcium carbonate D3 tablets were more cost-effective than calcium carbonate D3 tablets alone in patients with OP. Compared with Gushukang capsules, JCs had more cost-effectiveness advantages, but the sample size included in the study was small, and the results needed to be verified by further studies. Combined with the results of the Comparative Assessment of Structure Prediction (CASP) evaluation list, the comprehensive economic evaluation was Grade B. JCs were the only bionic medicine of tiger bone in China with all intellectual property rights, with 3 national invention patents. Its process preparation and fingerprint detection had obvious technical advantages. It had innovative advantages in the supply base equipment, medicine resource management, production technology, and other aspects. Thus, its innovative comprehensive evaluation was Grade A. JCs were in capsule dosage form, which was relatively convenient for storage and transportation. The dosage form was suitable for indications, and the usage was easy for patients to grasp and accept. The statutory information and non-statutory information met the national standards. The comprehensive evaluation of suitability was Grade A. JCs did not contain toxic ingredients, had no restrictions on origin and prescription, and had abundant resources of original medicinal materials. The affordability of JCs in the treatment of OP was good in urban areas (14.97%) but not in rural areas (39.76%). The price was higher than that of similar Chinese patent medicines, and the comprehensive evaluation of availability was Grade B. JCs had a reasonable proportion of natural animal bones, and their composition was basically the same as that of natural tiger bones. After marketing, more than 2 000 cases of real-world clinical research evidence was accumulated, and the comprehensive evaluation of TCM characteristics was Grade B. CSC v2.0 software was used for quantitative synthesis of the '6+1' dimension, and the comprehensive clinical value of JCs in the treatment of OP was Grade A. ConclusionJCs have good clinical value in the treatment of OP, and the TCM characteristics are prominent. It is suggested that JCs can be directly transformed into the related policy results of basic clinical drug management according to procedures.
5.Real World Safety of Shujin Jianyao Pills in 3 033 Cases Under Intensive Hospital Monitoring Based on Active Monitoring
Xin CUI ; Yuanyuan LI ; Weiheng CHEN ; Zujian XU ; Jinghua GAO ; Yanming XIE ; Li anxin WANG
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(15):102-110
ObjectiveTo further assess the safety of clinical application of Shujin Jianyao pills after marketing and find its potential risk factors as early as possible, to obtain the real world medication situation of Shujin Jianyao pills and its incidence of adverse reactions and clinical characteristics, and to explore the factors affecting the occurrence of adverse drug reactions (ADR). MethodIn this study, prospective, large-sample, multi-center and intensive whole-hospital monitoring with continuous registration was carried out, combined with telephone follow-up visits 2-4 weeks after the end of medication, for whole treatment course monitoring among patients. In addition, the three-level quality control was strictly implemented in the monitoring process. The study used a proprietary electronic data management system for data management, and SAS 9.4 and R software were used for statistical analysis. ResultFrom May 2018 to July 2020, the study completed the safety monitoring of 3 033 patients taking Shujin Jianyao pills in 30 clinical departments of 25 hospitals in China. A total of 36 ADR cases (49 times) were confirmed by expert assessment on data and supervision quality and expert interpretation of ADR. ConclusionAccording to the World Health Organization (WHO), the symptoms of adverse reactions were mainly classified into occasional adverse reactions (0.1%≤ADR<1%: abdominal distension, oral ulcer, dry mouth, constipation) and rare adverse reactions (0.01%≤ADR<0.1%: loss of appetite, rash, fatigue, increased ALT, increased creatinine, dizziness, stomachache, stomach distension, liver discomfort, pruritus, dysphoria, acid regurgitation, numbness in mouth, abdominal pain, sore throat, earache, tinnitus). Moreover, through the synthetic minority oversampling technique (SOMTE) combined with logistic regression, the following factors might affect ADR: taking Shujin Jianyao pills for 1-14 days, aged 46-65, 66-80 and 81 and above as well as combined use of atorvastatin, cobamamide, calcitriol capsules, Gushukang capsules, glucosamine, nifedipine, methylcobalamin, metformin, Tenghuang Jiangu pills, Bugu tablets, and diclofenac sodium sustained-release tablets. This study provided a real world basis for the safety and standardized use of Shujin Jianyao pills in clinical practice.
6.Comparison RNA with DNA detection assay in diagnosis of Mycoplasma pneumoniae infection
Hanqing ZHAO ; Chao YAN ; Yanling FENG ; Guanhua XUE ; Shaoli LI ; Jinghua CUI ; Hongmei SUN ; Jing YUAN
Chinese Journal of Applied Clinical Pediatrics 2021;36(10):736-739
Objective:To evaluate the rapid nucleic acid amplification detection of Mycoplasma pneumoniae (MP)-DNA and MP-RNA in the diagnosis of MP infection and therapeutic values in children. Methods:Patients who were diagnosed with pneumonia were enrolled from the Department of Respiration, Children′s Hospital of Capital Institute of Pediatrics from January 2018 to December 2018.Specimens were detected using the MP and Macrolide-Resistant isolates Diagnostic Kit (PCR Fluorescence Probing, Jiangsu Mole Bioscience Co., Ltd.) and MP Diagnostic Kit (Isothermal RNA amplification, Shanghai Rendu Biotechnology Co., Ltd.).Results:Among them, 42.1%(840 cases) of the 1 994 cases were positive for MP-DNA, and the macrolide associated gene mutations were detected in 96.0% (806/840 cases) of them, while 33.9% (551 cases) of 1 624 cases were positive for MP-RNA.Seven hundred and fifty-eight specimens were simultaneously detected by adopting MP-DNA and MP-RNA, and the positive rate was 43.1% (327/758 cases) and 36.7% (278/758 cases), accordingly, which were inconsistent (Kappa=0.604) in 613 (80.9%, 613/758 cases) cases, with significant differences ( χ2=6.60, P=0.01). Part of the specimens were rechecked with the interval of 7 days: MP-RNA was negative in 70.1% (47/67 cases) specimens and MP-DNA was negative in 36.1% (22/91 cases) specimens ( χ2=33.20, P<0.01). Conclusions:The positive detection rate of MP was at a high level in 2018, in Beijing, China.The results of MP-DNA and MP-RNA are consistant.But RNA detection can help to diagnose MP in the early stage, and monitor the survival of MP and its efficiency.
7.A study on risk factors of intestinal bacteria colonization and antibiotic resistance in NICU neonates
Zunjie LIU ; Xia CHEN ; Juan LI ; Zhigang CUI ; Jianrong MA ; Jinghua CUI
Chinese Journal of Neonatology 2020;35(2):118-122
Objective To study the risk factors of intestinal bacteria colonization and antibiotic resistance among newborns in neonatal intensive care unit (NICU).Method From May 2014 to May 2015,newborns admitted to NICU in our hospital were enrolled and their feces were prospectively collected and cultured from day 5 to day 7 after birth.VITEK-2 system was used to identify the bacteria and determine their antibiotic susceptibility.Newborns were assigned into 8 groups according to their gestational age,mode of delivery and use of antibiotics,and the colonization rates of Escherichia coli (E.coli),Enterococcus and Klebsiella pneumoniae were compared.Result A total of 572 feces of newborns were collected,328 strains of E.coli,243 strains of Enterococcus and 70 strains of Klebsiella pneumoniae were isolated.The multi-drug resistance rates of E.coli and Enterococcus were 68.3% (136/199) and 76.1% (185/243),respectively.The colonization rates of E.coli,Enterococcus and Klebsiella pneumoniae of the full-term delivery without antibiotics group (77 cases),full-term Cesarean section (C-section) without antibiotics group (30 cases),premature C-section without antibiotics group (28 cases),premature delivery without antibiotics group (16 cases),premature delivery with antibiotics group (53 cases),full-term delivery with antibiotics group (155 cases),full-term C-section with antibiotics group (99 cases),premature C-section with antibiotics group (114 cases) were different.The antibiotics groups showed significantly less E.coli colonization rates and higher Enterococcus colonization rates than the non-antibiotics groups of the same gestational age and delivery mode (P < 0.05).The result between the full-term C-section newborns and naturally delivered newborns without antibiotics indicated the similar trend (P < 0.05).The colonization rates of Klebsiella pneumoniae showed no significant differences among the groups (P > 0.05).Conclusion The multi-drug resistance of E.coli and Enterococcus in neonatal intestinal colonization is common and worrisome.Bacterial colonization is affected by antibiotics and the mode of delivery and prudent use of antibiotics is advised.
8. Antimicrobial resistance and molecular epidemiology of foodborne Yersinia enterocolitica in Pudong New District, Shanghai
Wenqing WANG ; Qiqi CUI ; Xiao WANG ; Yongqi ZHANG ; Caiyun LI ; Jinghua SU ; Bing ZHAO ; Hong HUANG ; Linying ZHU ; Xuebin XU ; Lipeng HAO
Chinese Journal of Epidemiology 2019;40(3):354-359
Objective:
To investigate the antimicrobial resistance and molecular epidemiology of foodborne
9.The effect of estimated glomerular filtration rate on outcome of patients with acute ischemic stroke after intravenous thrombolysis with recombinant tissue plasminogen activator
Hongfei PEI ; Xu TONG ; Ping YU ; Huaguang ZHENG ; Jing LIU ; Jinghua LIU ; Yueming TIAN ; Nan SHI ; Jingjing LI ; Ying CUI ; Yibin CAO
Chinese Journal of Neurology 2018;51(4):268-274
Objective To explore the association between estimated glomerular filtration rate (eGFR) and prognosis of acute ischemic stroke (AIS) patients who were treated by intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA).Methods We consecutively screened AIS patients who were treated by intravenous thrombolysis with rt-PA from January 2006 to September 2016 in Tangshan Gongren Hospital.According to eGFR value of patients at admission,the eligible patients were divided into two groups:normal eGFR group (eGFR ≥ 90 ml ? min-1 ? 1.73 m-2) and decreased eGFR group (eGFR < 90 ml? min-1 ? 1.73 m-2).The incidence of symptomatic intracerebral hemorrhage (SICH),early neurological deterioration (END) at 24 hours and seven days after thrombolysis,mortality within seven days and 90 days,and excellent recovery at 90 days were compared between the two groups.The OR with 95% CI and the adjusted OR with 95% CI were analyzed by univariate and multivariate Logistic regression models.Results A total of 258 patients were enrolled,including 182 cases in the normal eGFR group and 76 cases in the decreased eGFR group.After adjusting for the potential confounders,multivariate Logistic regression analysis showed that the rates of SICH (13.2% (10/76) vs 3.3% (6/182),OR =3.859,95% CI 1.313-11.341),END at 24 hours (21.1% (16/76) vs 8.2% (15/182),OR =2.958,95% CI 1.347-6.495) and seven days (32.9% (25/76) vs 12.6% (23/182),OR =3.129,95% CI 1.555-6.293),mortality within seven days (22.4% (17/76) vs 6.0% (11/182),OR =4.079,95% CI 1.588-10.477) and 90 days (23.7% (18/76) vs 9.9% (18/182),OR =2.457,95% CI 1.050-5.749) were higher in the decreased eGFR group than in the normal eGFR group.On the other hand,the chance of excellent recovery at 90 days (22.4% (17/76) vs 43.4% (79/182),OR =0.435,95% CI 0.229-0.824) was less in the decreased eGFR group than in the normal eGFR group.Conclusion Decreased eGFR may not only increase the risks of SICH,END and death,but also reduce the chance of 90-day excellent recovery in AIS patients after intravenous thrombolysis with rt-PA.
10.Study on antibiotic resistance of Escherichia coli and Enterococcus colonized in intestine of neonates from neonatal intensive care unit
Xiaofang LI ; Zunjie LIU ; Xia CHEN ; Juan LI ; Zhigang CUI ; Biao KAN ; Jianrong MA ; Jinghua CUI
Chinese Journal of Epidemiology 2017;38(9):1259-1262
Objective To understand the antibiotic resistance of bacteria colonized in intestine of the neonates from neonatal intensive care unit (NICU) and provide evidence to guide clinical antibiotic treatment.Methods From May,2014 to May,2015,a total of 572 stool samples were collected from the neonates of NICU in our hospital.Escherichia coli and Enterococcus were detected with VITEK-2 system.Results A total of 328 strains of E.coli and 243 strains of Enterococcus were isolated respectively in this study.The 199 strains of E.coli selected for drug susceptibility test showed lower resistant rate to imipenem,ertapenem,amikacin,nitrofurantoin,ranging from 0.50% to 3.52% and showed higher resistant rate to ampicillin,tetracycline,trimethoprim/sulfamethoxazole and cefazolin,ranging from 54.27% to 84.92%.No meropenem resistant strainsere were found.The percentage of ESBLs production strains was 45%.The multi drug resistance test showed that 34.6% of the strains were resistant to four antibiotics.Three strains were resistant to seven antibiotics.The 243 strains of Enterococcus showed lower resistant rate to quinupristin/dalfopristin,nitrofurantoin,streptomycin,ranging from 0.41% to 4.53% and showed higher resistant rate to ampicillin,benzylpenicillin,ciprofloxacin,tetracycline,gentamicin and erythromycin,ranging from 70.78% to 91.77%.No strains which were resistant to tigecycline,vancomycin,rina thiazole amine/ketone were found.The multi drug-resistance test showed that 86.5% of the strains were resistant to five antibiotics.Conclusions According to the analysis of the 199 strains ofE.coli and 243 strains of Enterococcus isolated from the neonates,we found that the resistance of intestinal bacteria in the neonates was very serious,showing multi drug resistance.It is necessary to use antibiotics according to the drug susceptibility test results in clinical treatment.

Result Analysis
Print
Save
E-mail